Office of the U.S. Trade Representative proposes further exemptions for medical products from tariffs

On March 21, local time, the Office of the United States Trade Representative (USTR) announced on its official website: “Today, the country is working hard to combat the global pandemic of COVID-19. In order to keep up with the fight against the epidemic, In the latest development, USTR has begun to publicly solicit opinions from the public, businesses, and government agencies. If they believe that Section 301 tariffs (taxed products) may need further modification, they can comment.” The Office of the U.S. Trade Representative stated that this public opinion collection The phase will last until June 25, 2020, and can be extended if appropriate, and it is hoped that all parties can submit comments as soon as possible.